E Fund Management (HK)’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.5K Sell
95
-112
-54% -$22.2K ﹤0.01% 394
2026
Q2
$38.8K Buy
207
+61
+42% +$8.91K 0.01% 212
2026
Q1
$14.2K Buy
+146
New +$14.7K 0.01% 275

Other funds holding RVMD

E Fund Management (HK)'s RVMD Position: Q3 2026 in Review

E Fund Management (HK) reduced its Revolution Medicines (RVMD) stake by 54% in Q3 2026, selling an estimated $22.2K and leaving 95 shares worth $19.5K. The position accounts for ﹤0.01% of the portfolio, ranked #394.

E Fund Management (HK) first reported a position in RVMD in Q1 2026 and has held it in 3 quarters since. The position peaked at $38.8K in Q2 2026. 759 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • E Fund Management (HK) held 95 shares of Revolution Medicines worth $19.5K as of Q3 2026.
  • E Fund Management (HK) sold 112 Revolution Medicines shares in Q3 2026, an estimated $22.2K.
  • Revolution Medicines made up ﹤0.01% of E Fund Management (HK)'s portfolio in Q3 2026, its #394 holding.
  • E Fund Management (HK) first reported a position in Revolution Medicines in Q1 2026 and has held it in 3 quarters since.
  • E Fund Management (HK)'s Revolution Medicines position peaked at $38.8K in Q2 2026.
  • 759 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on E Fund Management (HK)'s 13F filing for Q3 2026, filed 12 Nov 2026.